Senior Accountant, Formation Bio
$100-125k
+ Equity
End-to-end medical trial solutions
Be an early applicant
End-to-end medical trial solutions
101-200 employees
Be an early applicant
$100-125k
+ Equity
101-200 employees
Company mission
To bring new treatments to patients faster and more efficiently.
Role
Who you are
- We are looking for a driven and organized senior accountant who is excited to join a fast-paced and collaborative team
- This person should be ready to roll up their sleeves and get into the details
- 3+ years of experience in public accounting or in-house Finance/Accounting department with a bachelor’s degree in accounting/finance/related field
- Detail oriented and ownership mentality
- Willingness to go above and beyond expectations
- NetSuite or similar ERP experience
- GAAP proficient
- Strong understanding of how the financial statements interact
- Strong proficiency in Microsoft Excel
What the job involves
- The person who will excel in this role is a fast learner who will quickly learn how things are currently done, take full ownership of key processes and continually seek to identify and implement improvements
- This role is critical in enhancing the efficiency and structure of TrialSpark’s financial reporting
- Lead the monthly close and handle complex components of the process
- Manage the company’s expenses for 3rd party payments
- Perform monthly balance sheet reconciliations
- Conduct financial system implementations, integrations, and improvements
- Perform regular flux analysis to deliver key insights to the team and key stakeholders
- Collaborate with Strategic Finance to deliver insights from actuals and how they impact future results
- Collaborate cross-functionally with other departments
- Support technical accounting requests, such as stock comp, ASC 842, taxes as needed
- Assist in external financial audit with timely and accurate PBC requests and supporting schedules
- Respond to ad hoc financial requests and implement processes to support them
Our take
Clinical drug trials are lengthy and expensive, delaying the supply of vital new drugs to patients and costing lives. For Formation Bio, this is an efficiency issue - one which it hopes to solve with its end-to-end automation solution.
According to the company, its approach has teams running medical trials twice as fast and at half the cost. It's worked so well, in fact, that Formation Bio is looking to take drug development in-house.
Now a Unicorn, the company has secured heavyweights like Pfizer, Sanofi, Novartis and 23andMe as partners. Precisely how it will fare in the Big Pharma ecosystem remains to be seen, but the promise of cheaper drugs and faster innovation is certainly causing a stir in a market that has historically been resistant to both.
Kirsty
Company Specialist at Welcome to the Jungle
Insights
30% employee growth in 12 months
Company
Funding (last 2 of 3 rounds)
Jun 2024
$372m
SERIES D
Sep 2021
$156m
SERIES C
Total funding: $530.3m
Company HQ
Midtown South, New York, NY
Leadership
Benjamine Liu
(CEO)Worked as a computational biologist at various Neurology departments, following a D.Phil in computational Biology and Psychiatry at Oxford. They are also an Advisor at Harvard Business School.
Salary benchmarks
We don't have enough data yet to provide salary benchmarks for this role.
Submit your salary to help other candidates with crowdsourced salary estimates.
Share this job
View 7 more jobs at Formation Bio